<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font28">and </span>
   <span class="font17">for </span>
   <span class="font17">patients </span>
   <span class="font16">The </span>
   <span class="font16">were </span>
   <span class="font16">was </span>
   <span class="font15">with </span>
   <span class="font15">IPT </span>
   <span class="font15">study </span>
   <span class="font15">completion </span>
   <span class="font14">INH </span>
   <span class="font13">{background </span>
   <span class="font12">are </span>
   <span class="font12">that </span>
   <span class="font12">who </span>
   <span class="font12">HIV </span>
   <span class="font12">health </span>
   <span class="font12">improvement </span>
   <span class="font12">margin </span>
   <span class="font12">side </span>
   <span class="font12">adherence </span>
   <span class="font12">appointment </span>
   <span class="font12">effects </span>
   <span class="font12">{border-style </span>
   <span class="font12">all </span>
   <span class="font12">from </span>
   <span class="font12">outcomes </span>
   <span class="font12">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">active </span>
   <span class="font11">treatment </span>
   <span class="font11">among </span>
   <span class="font11">more </span>
   <span class="font11">[]. </span>
   <span class="font11">cohort </span>
   <span class="font11">national </span>
   <span class="font11">this </span>
   <span class="font11">ART </span>
   <span class="font11">collaborative </span>
   <span class="font11">than </span>
   <span class="font11">therapy </span>
   <span class="font11">which </span>
   <span class="font11">results </span>
   <span class="font11">not </span>
   <span class="font11">primary </span>
   <span class="font11">used </span>
   <span class="font11">Total </span>
   <span class="font11">care </span>
   <span class="font11">children </span>
   <span class="font11">disease </span>
   <span class="font11">have </span>
   <span class="font11">sites </span>
   <span class="font11">Health </span>
   <span class="font11">INH. </span>
   <span class="font11">TPT </span>
   <span class="font11">Table </span>
   <span class="font11">This </span>
   <span class="font11">characteristics </span>
   <span class="font11">complete </span>
   <span class="font11">intervention </span>
   <span class="font11">months </span>
   <span class="font11">patient </span>
   <span class="font11">preventive </span>
   <span class="font11">quality </span>
   <span class="font11">(%) </span>
   <span class="font11">(AOR = ., </span>
   <span class="font11">each </span>
   <span class="font11">initiated </span>
   <span class="font11">isoniazid </span>
   <span class="font11">likely </span>
   <span class="font11">other </span>
   <span class="font11">outcome </span>
   <span class="font11">possible </span>
   <span class="font11">prospective </span>
   <span class="font11">secondary </span>
   <span class="font11">their </span>
   <span class="font11">times </span>
   <span class="font10">Uganda. </span>
   <span class="font10">Yes </span>
   <span class="font10">associated </span>
   <span class="font10">both </span>
   <span class="font10">completion. </span>
   <span class="font10">dose </span>
   <span class="font10">one </span>
   <span class="font10">our </span>
   <span class="font10">public </span>
   <span class="font10">px; </span>
   <span class="font10">{font-family </span>
   <span class="font10">January </span>
   <span class="font10">Patients </span>
   <span class="font10">analysis </span>
   <span class="font10">but </span>
   <span class="font10">changes </span>
   <span class="font10">coaches </span>
   <span class="font10">determine </span>
   <span class="font10">documented </span>
   <span class="font10">drug </span>
   <span class="font10">end </span>
   <span class="font10">font-size </span>
   <span class="font10">found </span>
   <span class="font10">infection </span>
   <span class="font10">nested </span>
   <span class="font10">prevent </span>
   <span class="font10">p = ., </span>
   <span class="font10">such </span>
   <span class="font10">those </span>
   <span class="font10">tuberculosis </span>
   <span class="font10">However, </span>
   <span class="font10">Isoniazid </span>
   <span class="font10">Our </span>
   <span class="font10">Results </span>
   <span class="font10">Uganda </span>
   <span class="font10">authors </span>
   <span class="font10">control </span>
   <span class="font10">covariates </span>
   <span class="font10">delivery </span>
   <span class="font10">development </span>
   <span class="font10">double; </span>
   <span class="font10">findings </span>
   <span class="font10">given </span>
   <span class="font10">high </span>
   <span class="font10">included </span>
   <span class="font10">initiation </span>
   <span class="font10">keeping </span>
   <span class="font10">level </span>
   <span class="font10">longitudinal </span>
   <span class="font10">model </span>
   <span class="font10">out </span>
   <span class="font10">part </span>
   <span class="font10">people </span>
   <span class="font10">support </span>
   <span class="font10">teams </span>
   <span class="font10">tested </span>
   <span class="font10">using </span>
   <span class="font10">within </span>
   <span class="font10">years </span>
   <span class="font10">(.–.) </span>
   <span class="font10">AIDS </span>
   <span class="font10">Adherence </span>
   <span class="font10">All </span>
   <span class="font10">Commons </span>
   <span class="font10">Creative </span>
   <span class="font10">HIV-infected </span>
   <span class="font10">IPT. </span>
   <span class="font10">Ministry </span>
   <span class="font10">PLHIV </span>
   <span class="font10">adherence, </span>
   <span class="font10">adults </span>
   <span class="font10">also </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">can </span>
   <span class="font10">completed </span>
   <span class="font10">conducted </span>
   <span class="font10">defined </span>
   <span class="font10">df = ). </span>
   <span class="font10">drugs </span>
   <span class="font10">during </span>
   <span class="font10">factors </span>
   <span class="font10">improve </span>
   <span class="font10">living </span>
   <span class="font10">loss </span>
   <span class="font10">period </span>
   <span class="font10">positive </span>
   <span class="font10">prevention </span>
   <span class="font10">progress </span>
   <span class="font10">reported </span>
   <span class="font10">solid; </span>
   <span class="font10">stopped </span>
   <span class="font10">studies </span>
   <span class="font10">study. </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(n) </span>
   <span class="font10">(vitamin </span>
   <span class="font10">PEPFAR </span>
   <span class="font10">Patient </span>
   <span class="font10">Treatment </span>
   <span class="font10">Tuberculosis </span>
   <span class="font10">USAID </span>
   <span class="font10">WHO </span>
   <span class="font10">activities </span>
   <span class="font10">address </span>
   <span class="font10">analysis, </span>
   <span class="font10">antiretroviral </span>
   <span class="font10">any </span>
   <span class="font10">approved </span>
   <span class="font10">barriers </span>
   <span class="font10">between </span>
   <span class="font10">bold </span>
   <span class="font10">clinical </span>
   <span class="font10">collaborative. </span>
   <span class="font10">context </span>
   <span class="font10">courier; </span>
   <span class="font10">different </span>
   <span class="font10">disease, </span>
   <span class="font10">document </span>
   <span class="font10">em; </span>
   <span class="font10">guidelines </span>
   <span class="font10">had </span>
   <span class="font10">identify </span>
   <span class="font10">implementation </span>
   <span class="font10">improving </span>
   <span class="font10">incident </span>
   <span class="font10">interventions </span>
   <span class="font10">kept </span>
   <span class="font10">linear </span>
   <span class="font10">management </span>
   <span class="font10">mg/day </span>
   <span class="font10">month </span>
   <span class="font10">months. </span>
   <span class="font10">most </span>
   <span class="font10">multiple </span>
   <span class="font10">need </span>
   <span class="font10">odds </span>
   <span class="font10">outcomes. </span>
   <span class="font10">over </span>
   <span class="font10">patients. </span>
   <span class="font10">pt;} </span>
   <span class="font10">rates </span>
   <span class="font10">regression </span>
   <span class="font10">retention, </span>
   <span class="font10">review </span>
   <span class="font10">reviewed </span>
   <span class="font10">scheduled </span>
   <span class="font10">showed </span>
   <span class="font10">significant </span>
   <span class="font10">sites. </span>
   <span class="font10">six </span>
   <span class="font10">statistical </span>
   <span class="font10">study, </span>
   <span class="font10">under </span>
   <span class="font10">use </span>
   <span class="font10">volume </span>
   <span class="font10">when </span>
   <span class="font10">where </span>
   <span class="font10">worker </span>
  </p>
 </body>
</html>
